These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3927464)

  • 21. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.
    Fick RB; Naegel GP; Squier SU; Wood RE; Gee JB; Reynolds HY
    J Clin Invest; 1984 Jul; 74(1):236-48. PubMed ID: 6429195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas aeruginosa infection and humoral antibody response of patients with cystic fibrosis.
    Neter E
    J Infect Dis; 1974 Nov; 130 Suppl(0):S132-3. PubMed ID: 4213765
    [No Abstract]   [Full Text] [Related]  

  • 23. Opsonic defect in patients with cystic fibrosis of the pancreas.
    Biggar WD; Holmes B; Good RA
    Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1716-9. PubMed ID: 5001942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ; Lang A; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Schaad U
    Behring Inst Mitt; 1997 Feb; (98):345-9. PubMed ID: 9382759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of Pseudomonas aeruginosa exotoxin on various nonspecific factors of immunologic reactivity in an experiment].
    Dziubak ST
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):69-72. PubMed ID: 6412491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
    Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
    N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
    Winkler U; Wingender J; Jäger KE
    Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.
    Penketh AR; Pitt TL; Hodson ME; Batten JC
    J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent.
    Van de Weert-van Leeuwen PB; Van Meegen MA; Speirs JJ; Pals DJ; Rooijakkers SH; Van der Ent CK; Terheggen-Lagro SW; Arets HG; Beekman JM
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):463-70. PubMed ID: 23617438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interference of Pseudomonas aeruginosa with immunospecific host defenses.
    Petit JC; Daguet GL
    Biomed Pharmacother; 1983; 37(9-10):422-8. PubMed ID: 6232960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
    [No Abstract]   [Full Text] [Related]  

  • 33. Tissue-specific Fc gamma and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa.
    Berger M; Norvell TM; Tosi MF; Emancipator SN; Konstan MW; Schreiber JR
    Pediatr Res; 1994 Jan; 35(1):68-77. PubMed ID: 8134202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbial defenses of the child and man.
    Dossett JH
    Pediatr Clin North Am; 1972 May; 19(2):355-72. PubMed ID: 4555450
    [No Abstract]   [Full Text] [Related]  

  • 35. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis respiratory infections: interactions between bacteria and host defence.
    Döring G
    Monaldi Arch Chest Dis; 1997 Aug; 52(4):363-6. PubMed ID: 9401367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.
    Speert DP; Wong SY; Macdonald M; Sargeant R
    Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phagocytic and signaling innate immune receptors: are they dysregulated in cystic fibrosis in the fight against Pseudomonas aeruginosa?
    Sallenave JM
    Int J Biochem Cell Biol; 2014 Jul; 52():103-7. PubMed ID: 24508137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
    Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
    Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils.
    Thomsen K; Christophersen L; Jensen PØ; Bjarnsholt T; Moser C; Høiby N
    Hum Vaccin Immunother; 2016 Jul; 12(7):1690-9. PubMed ID: 26901841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.